RSV 감염에 의한 기도과민성의 발달
Respiratory Syncytial Virus Infection Induced Airway Hyperresponsiveness
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Respiratory viruses are known to play a role in the inception of asthma early in life. Respiratory syncytial virus (RSV) is the most common cause of infant bronchiolitis, which is associated with the development of childhood wheezing and asthma-like phenotype. Method: Animal models have played a pivotal role in studying the pathophysiology of viral respiratory infections. Various approaches to assessment of airway inflammation and function have been used to elucidate the mechanisms of RSV-induced airway hyperresponsiveness and to address clinically relevant questions regarding the role of RSV in wheezing and asthma after bronchiolitis. Result: Animal studies demonstrated that RSV induced airway hyperresponsiveness and enhanced allergen-sensitization in the host. This altered airway function is mediated through immune and neurogenic inflammatory mechanisms. Recent studies in mice have shown that neonatal RSV infection sensitizes the newborn to develop an asthma-like phenotype on reinfection, providing further opportunities to investigate the role of RSV in postbronchiolitis wheezing and asthma in animal models. Conclusion: Further studies are needed to fully establish the mechanisms underlying the pathophysiology of RSV infections and to clarify the role of RSV infections in the inception and/or progression of chronic airway diseases such as asthma.
Abstract
Background: Respiratory viruses are known to play a role in the inception of asthma early in life. Respiratory syncytial virus (RSV) is the most common cause of infant bronchiolitis, which is associated with the development of childhood wheezing and asthma-like phenotype. Method: Animal models have played a pivotal role in studying the pathophysiology of viral respiratory infections. Various approaches to assessment of airway inflammation and function have been used to elucidate the mechanisms of RSV-induced airway hyperresponsiveness and to address clinically relevant questions regarding the role of RSV in wheezing and asthma after bronchiolitis. Result: Animal studies demonstrated that RSV induced airway hyperresponsiveness and enhanced allergen-sensitization in the host. This altered airway function is mediated through immune and neurogenic inflammatory mechanisms. Recent studies in mice have shown that neonatal RSV infection sensitizes the newborn to develop an asthma-like phenotype on reinfection, providing further opportunities to investigate the role of RSV in postbronchiolitis wheezing and asthma in animal models. Conclusion: Further studies are needed to fully establish the mechanisms underlying the pathophysiology of RSV infections and to clarify the role of RSV infections in the inception and/or progression of chronic airway diseases such as asthma.
참고문헌 (53)
- Martinez FD, "Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma", Pediatr Infect Dis J, 22, pp.S76~S82 (2003)
- Perez-Yarza EG, "The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature", Pediatr Infect Dis J, 26, pp.733~739 (2007)
- Dakhama A, "Virus-induced airway dysfunction: pathogenesis and biomechanisms", Pediatr Infect Dis J, 24, pp.S159~S169 (2005)
- Singh AM, "Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation", Am J Respir Crit Care Med, 175, pp.108~119 (2007)
- Culley FJ, "Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood", J Exp Med, 196, pp.1381~1386 (2002)
- Dakhama A, "The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production", J Immunol, 175, pp.1876~1883 (2005)
- Lybarger L, "Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways", Curr Opin Immunol, 17, pp.71~78 (2005)
- Blair GE, "Evasion of the immune system by adenoviruses", Curr Top Microbiol Immunol, 273, pp.3~28 (2004)
- LeVine AM, "Pulmonary collectins and innate host defense of the lung", Microbes Infect, 3, pp.161~166 (2001)
- Taube C, "Insights into the pathogenesis of asthma utilizing murine models", Int Arch Allergy Immunol, 135, pp.173~186 (2004)
- Hall CB, "Respiratory syncytial virus: A continuing culprit and conundrum", J Pediatr, 135, pp.2~7 (1999)
- Falsey AR, "Respiratory syncytial virus infection in elderly and high-risk adults", N Engl J Med, 352, pp.1749~1759 (2005)
- McGill A, "Detection of human respiratory syncytial virus genotype specific antibody responses in infants", J Med Virol, 74, pp.492~498 (2004)
- Hall CB, "Immunity to and frequency of reinfection with respiratory syncytial virus", J Infect Dis, 163, pp.693~698 (1991)
- Glezen WP, "Risk of primary infection and reinfection with respiratory syncytial virus", Am J Dis Child, 140, pp.543~546 (1986)
- Folkerts G, "Virus-induced airway hyperresponsiveness and asthma", Am J Respir Crit Care Med, 157, pp.1708~1720 (1998)
- Wark PA, "Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus", J Exp Med, 201, pp.937~947 (2005)
- Thurlbeck WM, "Pathology of chronic airflow obstruction", Chest, 97, pp.6S~10S (1990)
- Goldie RG, "Mechanisms of increased airway microvascular permeability: role in airway inflammation and obstruction", Clin Exp Pharmacol Physiol, 22, pp.387~396 (1995)
- Pare PD, "The functional consequences of airway remodeling in asthma", Monaldi Arch Chest Dis, 52, pp.589~596 (1997)
- Jacoby DB, "Virus-induced asthma attacks", JAMA, 287, pp.755~761 (2002)
- Larsen GL, "Neural control mechanisms within airways: disruption by respiratory syncytial virus", J Pediatr, 135, pp.21~27 (1999)
- Tripp RA, "Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection", J Neuroimmunol, 129, pp.141~153 (2002)
- Tripp RA, "Respiratory syncytial virus infection and G and", or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB, J Virol, pp.2000, 74[DOI]
- King KA, "Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats", Am J Respir Cell Mol Biol, 24, pp.101~107 (2001)
- Dakhama A, "Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection", Am J Physiol Lung Cell Mol Physiol, 288, pp.L761~L770 (2005)
- Dakhama A, "Calcitonin gene-related peptide: role in airway homeostasis", Curr Opin Pharmacol, 4, pp.215~220 (2004)
- Schwarze J, "Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen", J Clin Invest, 100, pp.226~233 (1997)
- Jafri HS, "Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice", J Infect Dis, 189, pp.1856~1865 (2004)
- Graham BS, "Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice", J Clin Invest, 88, pp.1026~1033 (1991)
- Gelfand EW, "Induction and maintenance of airway responsiveness to allergen challenge are determined at the age of initial sensitization", J Immunol, 173, pp.1298~1306 (2004)
- Wills-Karp M, "Interleukin-13: central mediator of allergic asthma", Science, 282, pp.2258~2261 (1998)
- Kuperman DA, "Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma", Nat Med, 8, pp.885~889 (2002)
- Walter DM, "Critical role for IL-13 in the development of allergen-induced airway hyperreactivity", J Immunol, 167, pp.4668~1675 (2001)
- Taube C, "The role of IL-13 in established allergic airway disease", J Immunol, 169, pp.6482~6489 (2002)
- Lee YM, "IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus", Am J Respir Crit Care Med, 177, pp.208~218 (2008)
- Welliver RC, "The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection", N Engl J Med, 303, pp.1198~1202 (1980)
- Dakhama A, "The role of virus-specific immunoglobulin E in airway hyperresponsiveness", Am J Respir Crit Care Med, 170, pp.952~959 (2004)
- Dakhama A, "Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice", J Allergy Clin Immunol, 123, pp.138~145 (2009)
- Frick OL, "Development of allergy in children. I. Association with virus infections", J Allergy Clin Immunol, 63, pp.228~241 (1979)
- Busse WW, "The relationship between viral infections and onset of allergic diseases and asthma", Clin Exp Allergy, 19, pp.1~9 (1989)
- Sigurs N, "Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13", Am J Respir Crit Care Med, 171, pp.137~141 (2005)
- O'Donnell DR, "Anaphylactic sensitization to aeroantigen during respiratory virus infection", Clin Exp Allergy, 28, pp.1501~1508 (1998)
- Stephens R, "Antigen-nonspecific recruitment of Th2 cells to the lung as a mechanism for viral infection-induced allergic asthma", J Immunol, 169, pp.5458~5467 (2002)
- John AE, "Respiratory syncytial virus-induced CCL5", RANTES contributes to exacerbation of allergic airway inflammation, 2003, pp.33, 1677~1685
- Makela MJ, "Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness", J Allergy Clin Immunol, 112, pp.861~869 (2003)
- Schwarze J, "Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes", J Immunol, 163, pp.5729~5734 (1999)
- Lemanske RF Jr, "Viruses and asthma: Inception, exacerbation, and possible prevention", J Pediatr, 142, pp.S3~S7 (2003)
- Frost GD, "Asthma-related prescribing patterns with four different corticosteroid inhaler devices", Respir Med, 92, pp.1352~1358 (1998)
- Welliver RC, "Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection", J Pediatr, 143, pp.S112~S117 (2003)
- Stein RT, "Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years", Lancet, 354, pp.541~545 (1999)
- Schwarze J, "Respiratory viral infections as promoters of allergic sensitization and asthma in animal models", Eur Respir J, 19, pp.341~349 (2002)
- Kalina WV, "Progress in defining the role of RSV in allergy and asthma: from clinical observations to animal models", Clin Dev Immunol, 11, pp.113~119 (2004)
